Patents by Inventor Georges Gaudriault

Georges Gaudriault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
    Patent number: 11865205
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: January 9, 2024
    Assignee: MEDINCELL S.A.
    Inventors: Georges Gaudriault, Sylvestre Grizot, Mark Hurtig, Matthew Shive
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20240000703
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: September 15, 2023
    Publication date: January 4, 2024
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20230091533
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: September 23, 2022
    Publication date: March 23, 2023
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
    Publication number: 20220354956
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle or hydrophobic active principle such as medroxyprogesterone acetate, levonorgestrel, cyclosporine, progesterone or bupivacaine is disclosed.
    Type: Application
    Filed: May 19, 2022
    Publication date: November 10, 2022
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Christophe ROBERGE
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20220202942
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: January 10, 2022
    Publication date: June 30, 2022
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20210322302
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: January 25, 2021
    Publication date: October 21, 2021
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20210154301
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: August 3, 2020
    Publication date: May 27, 2021
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20210038724
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: October 14, 2020
    Publication date: February 11, 2021
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
    Publication number: 20210008216
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle or hydrophobic active principle such as medroxyprogesterone acetate, levonorgestrel, cyclosporine, progesterone or bupivacaine is disclosed.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 14, 2021
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Christophe ROBERGE
  • METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE
    Publication number: 20200155449
    Abstract: A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 21, 2020
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Sylvestre GRIZOT, Mark HURTIG, Matthew SHIVE
  • BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
    Publication number: 20200085958
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle or hydrophobic active principle such as medroxyprogesterone acetate, levonorgestrel, cyclosporine, progesterone or bupivacaine is disclosed.
    Type: Application
    Filed: November 22, 2019
    Publication date: March 19, 2020
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Christophe ROBERGE
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20190192665
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: September 21, 2018
    Publication date: June 27, 2019
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
    Publication number: 20190160171
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle or hydrophobic active principle such as medroxyprogesterone acetate, levonorgestrel, cyclosporine, progesterone or bupivacaine is disclosed.
    Type: Application
    Filed: July 30, 2018
    Publication date: May 30, 2019
    Applicant: MEDINCELL
    Inventors: Georges GAUDRIAULT, Christophe ROBERGE
  • Retro-inverso analogs of spadin display increased antidepressant effects
    Patent number: 10251937
    Abstract: Compositions, pharmaceutical compositions and biodegradable pharmaceutical compositions containing at least one analog of spadin or at least one analog of a propeptides of spadin or mixtures thereof are described. Methods for treating depression using the analogs of spadin or analogs of propeptides of spadin or mixtures thereof, as well as methods for blocking TREK-1 channel activity are also disclosed.
    Type: Grant
    Filed: January 27, 2015
    Date of Patent: April 9, 2019
    Assignees: MEDINCELL, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Georges Gaudriault, Catherine Heurteaux, Jean Mazella, Marc Borsotto, Hamid Moha Ou Maati, Julie Veyssiere
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20190099495
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: August 2, 2018
    Publication date: April 4, 2019
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • RETRO-INVERSO ANALOGS OF SPADIN DISPLAY INCREASED ANTIDEPRESSANT EFFECTS
    Publication number: 20170072013
    Abstract: Compositions, pharmaceutical compositions and biodegradable pharmaceutical compositions containing at least one analog of spadin or at least one analog of a propeptides of spadin or mixtures thereof are described. Methods for treating depression using the analogs of spadin or analogs of propeptides of spadin or mixtures thereof, as well as methods for blocking TREK-1 channel activity are also disclosed.
    Type: Application
    Filed: January 27, 2015
    Publication date: March 16, 2017
    Applicants: MEDINCELL, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Georges GAUDRIAULT, Catherine HEURTEAUX, Jean MAZELLA, Marc BORSOTTO, Hamid MOHA OU MAATI, Julie VEYSSIERE
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20160030581
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: October 14, 2015
    Publication date: February 4, 2016
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
    Publication number: 20150157727
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Application
    Filed: February 12, 2015
    Publication date: June 11, 2015
    Applicant: MEDINCELL
    Inventor: Georges GAUDRIAULT
  • BIODEGRADABLE DRUG DELIVERY FOR HYDROPHOBIC COMPOSITIONS
    Publication number: 20150150987
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethyl-ene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle or hydrophobic active principle such as medroxyprogesterone acetate, levonorgestrel, cyclosporine, progesterone or bupivacaine is disclosed.
    Type: Application
    Filed: June 27, 2013
    Publication date: June 4, 2015
    Applicant: MEDINCELL
    Inventors: Georges Gaudriault, Christophe Roberge
  • Biodegradable drug delivery compositions
    Patent number: 9023897
    Abstract: A biodegradable drug delivery compositions comprising a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as a pharmaceutically active principle is disclosed.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: May 5, 2015
    Assignee: MedinCell
    Inventor: Georges Gaudriault